ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (“ZIVO” or the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces the commercialization of its proprietary algal biomass as a food or food ingredient.

ZIVO has engaged an independent distributor, ZWorldwide, Inc., who will launch the product, branded Zivolife^TM, with an initial focus on North America. ZIVO and ZWorldwide are parties to an exclusive commercial agreement that is expected to result in ongoing product sales by ZIVO.

ZIVO also announces the signing of a contract manufacturing agreement with Alimenta Algae SAC (“Alimenta Algae”) to grow and process the algal biomass at facilities previously utilized by ZIVO for development in Peru. Alimenta Algae is the microalgae subsidiary of Grupo Alimenta, a global, multi-generational, family-run agribusiness with headquarters in Lima, Peru.

“Zivolife^TM is the Company’s first revenue-generating product, and its commercial availability and the establishment of a cohesive supply chain marks our entry into the global algae food market. After years of rigorous R&D and product testing, we’re proud to make Zivolife^TM available to consumers who are looking for a sustainable, whole-food product that delivers a wide range of nutrients that contribute to their overall health. We look forward to growing the market for Zivolife^TM, launching more products based on our proprietary algae, and will also continue to aggressively pursue the opportunities we have in the biotech and pharma markets,” said John Payne, CEO and Chairman of ZIVO Bioscience.

The global food and beverage microalgae market is projected to reach $247 million by 2033. The Company’s dried algal powder is a whole-food entrant into this fast-growing and premium segment. The rapid growth in demand for plant-based protein sources is being driven by trends in healthy living, environmental sustainability and ethical considerations. The target market for Zivolife^TM is consumers of microalgae and so-called “green drinks” who would benefit from a whole-food supplement to their diet, as well as conscious consumers who value sustainable products with exceptional nutritional profiles.